기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
Efficient Transduction with Recombinant Adenovirus in EBV-transformed B Lymphoblastoid Cell Lines
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • Efficient Transduction with Recombinant Adenovirus in EBV-transformed B Lymphoblastoid Cell Lines
  • Efficient Transduction with Recombinant Adenovirus in EBV-transformed B Lymphoblastoid Cell Lines
저자명
Kim. Hye-Jin,Cho. Hyun-Il,Han. Yoon-Hee,Park. Soo-Young,Kim. Dong-Wook,Lee. Dong-Gun,Kim. Jee-Hoon,Shin. Wan-Shik,Paik. Soon-You
간행물명
Journal of biochemistry and molecular biology
권/호정보
2004년|37권 3호|pp.376-382 (7 pages)
발행정보
생화학분자생물학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

The Epstein-Barr-transformed B lymphoblastoid cell lines, LCL, which express antigens, are potential antigen-presenting cells (APCs) for the induction of cytotoxic T lymphocytes in vitro. However, transfecting LCL with subsequent selection by antibiotics is notoriously difficult because the plating efficiencies of LCL are reported to be 1% or less. Therefore, this study investigated the optimal conditions for increasing the transduction efficiency of a recombinant adenovirus to LCL for use as a source of APCs. The transduction efficiencies were < 13% (SD $pm$ 2.13) at a multiplicity of infection (MOI) of 100, while it was increased to 28% (SD $pm$ 9.43) at an MOI of 1000. Moreover, its efficiencies to LCL that expressed the coxsackie adenovirus receptor were increased to 60% (SD $pm$ 6.35) at an MOI of 1000, and were further increased to 70% (SD $pm$ 4.56) when combined with the centrifugal method. The cationic liposome or anionic polymer had no effect on the transduction efficiency when compared to that of the centrifugal method. These results may be used as a convenient source of target cells for a CTL assay and/or autologous APCs for the induction of the in vitro CTL responses that are specific to viral and tumor antigens.